Gamida Cell (GMDAQ) Stock Price, News & Analysis

Company Overview

Gamida Cell Ltd. is a biopharmaceutical company. It focuses on developing cell therapies to cure cancer and rare and serious hematologic diseases. The company's product pipeline consists of NiCord and NAM-NK which are in clinical stage. It operates primarily in the United States, the European Union and internationally. Gamida Cell Ltd. is headquartered in Jerusalem, Israel.

Key Stats

• Today's Range: $0.0160 to $0.0183
• 50-Day Range: $0.0170 to $0.0170
• 52-Week Range: $0.01 to $2.51
• Volume: 332,754 shs
• Average Volume: 6.58 million shs
• Market Capitalization: $2.62 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 5/05/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Biological products, except diagnostic
• Sub-Industry: N/A
• Current Symbol: NASDAQ:GMDAQ
• CIK: 1600847
• Web: www.gamida-cell.com
• Phone: 617-892-9080
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.49)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-63,000,000.00
• Net Margins: N/A
• Pretax Margin: -2,317.95%
• Return on Equity: N/A
• Return on Assets: -60.18%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.35
• Quick Ratio: 0.33

Sales & Book Value

• Annual Sales: $1.78 million
• Price / Sales: 1.47
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.02) per share
• Price / Book: -0.85

Miscellaneous

• Outstanding Shares: 154,050,000
• Free Float: 143,699,000
• Market Cap: $2.62 million
• Optionable: Optionable
• Beta: 1.30